Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HUHTAMAKI.NS Stock Summary
Top 10 Correlated ETFs
HUHTAMAKI.NS
In the News
HUHTAMAKI.NS Financial details
Company Rating
Neutral
Market Cap
25.09B
Income
4.1B
Revenue
24.81B
Book val./share
-
Cash/share
-
Dividend
2
Dividend %
0.61%
Employees
2.5K
Optionable
No
Shortable
Yes
Earnings
24 Apr 2024
P/E
25.15
Forward P/E
-
PEG
0.35
P/S
0.9
P/B
-
P/C
-
P/FCF
1972.18
Quick Ratio
-
Current Ratio
-
Debt / Equity
0.22
LT Debt / Equity
0.21
-
-
EPS (TTM)
54.24
EPS next Y
-
EPS next Q
-
EPS this Y
725.57%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
19.22%
Revenue last 5Y
-0.53%
Revenue Q/Q
-9.17%
EPS Q/Q
915.46%
-
-
-
-
SMA20
4.13%
SMA50
-0.91%
SMA100
6.15%
Inst Own
-
Inst Trans
-
ROA
-
ROE
26%
ROC
-
Gross Margin
29%
Oper. Margin
5%
Profit Margin
4%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
208.9-371.0
52W High
-11.13%
52W Low
+58.51%
RSI
56
Rel Volume
0.25
Avg Volume
201.9K
Volume
50.79K
Perf Week
0.86%
Perf Month
-4.82%
Perf Quarter
14.14%
Perf Half Y
16.26%
-
-
-
-
Beta
-0.006
-
-
Volatility
3.63%, 11.96%
Prev Close
0.35%
Price
329.7
Change
-1.49%
HUHTAMAKI.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 337.34 | 320.28 | 340.41 | 386.18 | 328.56 | |
Net income per share | 22.52 | 12.71 | -3 | 6.57 | 54.24 | |
Operating cash flow per share | 37.67 | 22.42 | -3.66 | 17.56 | 36.23 | |
Free cash flow per share | 28.73 | 15.95 | -14.14 | 4.79 | 23.66 | |
Cash per share | 13.85 | 11.22 | 4.25 | 5.85 | 52.36 | |
Book value per share | 92.34 | 101.28 | 94.81 | 100.23 | 152.33 | |
Tangible book value per share | 82.72 | 91.2 | 85.24 | 91.26 | 143.43 | |
Share holders equity per share | 92.34 | 101.28 | 94.81 | 100.23 | 152.33 | |
Interest debt per share | 40.14 | 42.47 | 57.67 | 58.53 | 37.75 | |
Market cap | 18.65B | 23.68B | 17.19B | 15.06B | 22.29B | |
Enterprise value | 20.94B | 25.96B | 20.97B | 18.73B | 23.39B | |
P/E ratio | 10.97 | 24.67 | -75.77 | 30.33 | 5.44 | |
Price to sales ratio | 0.73 | 0.98 | 0.67 | 0.52 | 0.9 | |
POCF ratio | 6.56 | 13.98 | -62.13 | 11.35 | 8.15 | |
PFCF ratio | 8.6 | 19.65 | -16.1 | 41.64 | 12.48 | |
P/B Ratio | 2.67 | 3.1 | 2.4 | 1.99 | 1.94 | |
PTB ratio | 2.67 | 3.1 | 2.4 | 1.99 | 1.94 | |
EV to sales | 0.82 | 1.07 | 0.82 | 0.64 | 0.94 | |
Enterprise value over EBITDA | 6.86 | 11.01 | 18.54 | 10.75 | 10.91 | |
EV to operating cash flow | 7.36 | 15.33 | -75.77 | 14.12 | 8.55 | |
EV to free cash flow | 9.65 | 21.55 | -19.63 | 51.79 | 13.09 | |
Earnings yield | 0.09 | 0.04 | -0.01 | 0.03 | 0.18 | |
Free cash flow yield | 0.12 | 0.05 | -0.06 | 0.02 | 0.08 | |
Debt to equity | 0.39 | 0.39 | 0.57 | 0.54 | 0.22 | |
Debt to assets | 0.18 | 0.19 | 0.23 | 0.23 | 0.13 | |
Net debt to EBITDA | 0.75 | 0.97 | 3.34 | 2.11 | 0.51 | |
Current ratio | 1.35 | 1.45 | 1.34 | 1.44 | 2.15 | |
Interest coverage | 7.14 | 5.28 | 0.78 | 2.73 | 5.28 | |
Income quality | 1.41 | 1.44 | 46.9 | 2.37 | 0.55 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.16 | 0.24 | -1 | 0.16 | 0.04 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.02 | 0.01 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.05 | 0.05 | 0.04 | 0.04 | 0.03 | |
Capex to operating cash flow | -0.24 | -0.29 | 2.86 | -0.73 | -0.35 | |
Capex to revenue | -0.03 | -0.02 | -0.03 | -0.03 | -0.04 | |
Capex to depreciation | -0.78 | -0.5 | -0.86 | -1.12 | -1.78 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 216.28 | 170.19 | 80.06 | 121.75 | 431.17 | |
ROIC | 0.19 | 0.1 | 0.01 | 0.06 | 0.09 | |
Return on tangible assets | 0.12 | 0.06 | -0.01 | 0.03 | 0.21 | |
Graham Net | -17.1 | -28.36 | -54.44 | -38.49 | 12.4 | |
Working capital | 2.46B | 2.82B | 2.78B | 3.23B | 6.76B | |
Tangible asset value | 6.25B | 6.89B | 6.44B | 6.89B | 10.83B | |
Net current asset value | 1.26B | 958.2M | 79.2M | 686M | 4.1B | |
Invested capital | 0.39 | 0.39 | 0.57 | 0.54 | 0.22 | |
Average receivables | 6.13B | 5.98B | 5.87B | 6.57B | 6.16B | |
Average payables | 3.96B | 4.2B | 4.92B | 5.26B | 4.73B | |
Average inventory | 1.97B | 2.05B | 2.88B | 3.23B | 2.84B | |
Days sales outstanding | 94 | 81.41 | 89.97 | 85.08 | 81.15 | |
Days payables outstanding | 91.59 | 92.77 | 111.86 | 79.89 | 98.25 | |
Days of inventory on hand | 38.77 | 51.79 | 67.75 | 49.81 | 56.72 | |
Receivables turnover | 3.88 | 4.48 | 4.06 | 4.29 | 4.5 | |
Payables turnover | 3.99 | 3.93 | 3.26 | 4.57 | 3.72 | |
Inventory turnover | 9.41 | 7.05 | 5.39 | 7.33 | 6.43 | |
ROE | 0.24 | 0.13 | -0.03 | 0.07 | 0.36 | |
Capex per share | -8.95 | -6.47 | -10.48 | -12.78 | -12.57 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 89.77 | 85.54 | 80.22 | 85.31 | 0 | |
Net income per share | 2.23 | 4.7 | 1.91 | 4.27 | 0 | |
Operating cash flow per share | 0.16 | 4.13 | 3.06 | 2.87 | 0 | |
Free cash flow per share | 0.16 | 4.13 | 3.06 | 2.87 | 0 | |
Cash per share | 5.86 | 5.65 | 7.12 | 6.83 | 0 | |
Book value per share | 100.45 | 100.23 | 104.94 | 104.94 | 0 | |
Tangible book value per share | 91.46 | 0 | 96.18 | 0 | 0 | |
Share holders equity per share | 100.45 | 100.23 | 104.94 | 104.94 | 0 | |
Interest debt per share | 55.51 | 0.9 | 56.03 | 1 | 0 | |
Market cap | 15.02B | 14.31B | 20.63B | 19.43B | 0 | |
Enterprise value | 18.7B | 14.74B | 24.25B | 19.94B | 1.1B | |
P/E ratio | 22.3 | 10.08 | 35.66 | 15.05 | 0 | |
Price to sales ratio | 2.22 | 2.22 | 3.4 | 3.02 | 0 | |
POCF ratio | 1.27K | 45.9 | 89.29 | 89.7 | 0 | |
PFCF ratio | 1.27K | 45.9 | 89.29 | 89.7 | 0 | |
P/B Ratio | 1.98 | 1.89 | 2.6 | 2.45 | 0 | |
PTB ratio | 1.98 | 1.89 | 2.6 | 2.45 | 0 | |
EV to sales | 2.76 | 2.28 | 4 | 3.1 | 0.19 | |
Enterprise value over EBITDA | 41 | 25.6 | 57.6 | 40.91 | 1.78 | |
EV to operating cash flow | 1.58K | 47.27 | 104.96 | 92.08 | 4.92 | |
EV to free cash flow | 1.58K | 47.27 | 104.96 | 92.08 | 4.92 | |
Earnings yield | 0.01 | 0.02 | 0.01 | 0.02 | 0 | |
Free cash flow yield | 0 | 0.02 | 0.01 | 0.01 | 0 | |
Debt to equity | 0.54 | 0 | 0.52 | 0 | 0.22 | |
Debt to assets | 0.23 | 0 | 0.23 | 0 | 0.13 | |
Net debt to EBITDA | 8.05 | 0.74 | 8.6 | 1.06 | 1.78 | |
Current ratio | 1.44 | 0 | 1.47 | 0 | 2.15 | |
Interest coverage | 2.88 | 6.16 | 3.07 | 5.04 | 8.11 | |
Income quality | 0.07 | 0.88 | 1.6 | 0.67 | 0.07 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.04 | 0 | 0.04 | 0 | 0.03 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 71.07 | 102.95 | 67.24 | 100.44 | 0 | |
ROIC | 0.02 | 0.06 | 0.02 | 0.05 | 0.03 | |
Return on tangible assets | 0.01 | 0 | 0.01 | 0 | 0.17 | |
Graham Net | -38.57 | 5.65 | -38.51 | 6.83 | 0 | |
Working capital | 3.23B | 426.5M | 3.34B | 515.7M | 6.76B | |
Tangible asset value | 6.89B | 0 | 7.26B | 0 | 10.83B | |
Net current asset value | 686M | 426.5M | 773.1M | 515.7M | 4.1B | |
Invested capital | 0.54 | 0 | 0.52 | 0 | 0.22 | |
Average receivables | 3.4B | 3.4B | 3.09B | 3.09B | 2.76B | |
Average payables | 2.39B | 2.39B | 2.27B | 2.27B | 2.34B | |
Average inventory | 1.49B | 1.49B | 1.6B | 1.6B | 1.35B | |
Days sales outstanding | 90.44 | 0 | 91.77 | 0 | 84.85 | |
Days payables outstanding | 86.03 | 0 | 96.26 | 0 | 105.76 | |
Days of inventory on hand | 53.64 | 0 | 67.67 | 0 | 61.06 | |
Receivables turnover | 1 | 0 | 0.98 | 0 | 1.06 | |
Payables turnover | 1.05 | 0 | 0.94 | 0 | 0.85 | |
Inventory turnover | 1.68 | 0 | 1.33 | 0 | 1.47 | |
ROE | 0.02 | 0.05 | 0.02 | 0.04 | 0.28 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
HUHTAMAKI.NS Frequently Asked Questions
What is Huhtamaki India Limited stock symbol ?
Huhtamaki India Limited is a IN stock and trading under the symbol HUHTAMAKI.NS
What is Huhtamaki India Limited stock quote today ?
Huhtamaki India Limited stock price is $329.7 today.
Is Huhtamaki India Limited stock public?
Yes, Huhtamaki India Limited is a publicly traded company.
Something similar
Top Correlated ETFs